Resolution of primary amyloidosis during chemotherapy. Studies in a patient with nephrotic syndrome

scientific article published on 01 April 1975

Resolution of primary amyloidosis during chemotherapy. Studies in a patient with nephrotic syndrome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.7326/0003-4819-82-4-466
P698PubMed publication ID1119764

P2093author name stringH. J. Cohen
L. S. Lessin
J. Hallal
P. Burkholder
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectnephrotic syndromeQ504790
chemotherapyQ974135
AL amyloidosisQ4652470
P304page(s)466-473
P577publication date1975-04-01
P1433published inAnnals of Internal MedicineQ564416
P1476titleResolution of primary amyloidosis during chemotherapy. Studies in a patient with nephrotic syndrome
P478volume82

Reverse relations

cites work (P2860)
Q34539341Aberrant immunoglobulin synthesis in light chain amyloidosis. Free light chain and light chain fragment production by human bone marrow cells in short-term tissue culture
Q41028921Amyloid deposition in a renal allograft in a case of amyloidosis secondary to rheumatoid arthritis
Q36721257Amyloid myopathy and myeloma: response to treatment
Q34722948Amyloidosis: prognosis and treatment
Q35960394Clinical and laboratory findings in primary generalized and multiple-myeloma-related amyloidosis
Q40709737Colchicine in the treatment of AA and AL amyloidosis
Q35817991Colchicine therapy for nephrotic syndrome due to familial Mediterranean fever
Q39359280Current therapeutic strategies in cardiac amyloidosis
Q40846581De novo amyloidosis in a renal allograft: a case report and review of the literature
Q40333303Dubious effect of dimethylsulphoxide (DMSO) therapy on amyloid deposits and amyloidosis
Q44386418Endocarditis in Hemodialysis Patients with Systemic Disease
Q66700298Low-dose oral propranolol
Q33860770Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report
Q36714273Pattern of renal amyloidosis in Indian patients
Q78156195Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis
Q40511166Primary Amyloidosis with Cardiac Involvement Diagnosed by Left Ventricular Endomyocardial Biopsy
Q35780699Primary amyloidosis, paraproteinaemia and neuropathy
Q68210320Primary perireticulin amyloidosis in a 14-year-old girl
Q40603855Pulmonary Alveolar-Septal Amyloidosis Associated with Pulmonary Tuberculosis and an Unusual Paraproteinaemia
Q39377343Renal amyloidosis
Q66700299Resolution of amyloidosis and plasma-cell dyscrasia with combination chemotherapy
Q39852543Response of primary hepatic amyloidosis to melphalan and prednisone: a case report and review of the literature
Q71570744Subepithelial argyrophilic spicular structures in renal amyloidosis--an aid in diagnosis. Pathogenic considerations
Q39852954Systemic amyloidosis and the skin: a review with special emphasis on clinical features and therapy
Q40544138The Successful Treatment of Primary Amyloidosis with Intermittent Chemotherapy
Q43170618The kidney in myeloma
Q35610846Therapy for immunoglobulin light chain amyloidosis: the new and the old.
Q51033339Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only.
Q39891751Ultrastructural studies on the evolution of amyloidosis in the cyclic hematopoietic (CH) dog
Q71444865[Primary amyloidosis with nephrotic syndrome: 5 year follow-up under polychemotherapy. A case report (author's transl)]
Q66700297beta-Adrenoceptor blockers, plasma-potassium, and exercise

Search more.